)
Allogene Therapeutics (ALLO) investor relations material
Allogene Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Appointment of Zachary Roberts, M.D., Ph.D. as President and CEO effective July 1, 2026, succeeding David Chang, M.D., Ph.D.
Dr. Roberts will also join the Board as a Class I director, serving until the 2028 annual meeting.
Dr. Chang will transition to a non-employee director role and receive compensation per the non-employee director policy.
Voting matters and shareholder proposals
No changes to proxy cards; previously submitted votes remain valid for the June 18, 2026 annual meeting.
Instructions for voting, changing, or revoking proxies are detailed in the Proxy Statement.
Board of directors and corporate governance
Dr. Roberts appointed to the Board as a Class I director, bringing extensive life sciences and leadership experience.
Board and Nominating and Corporate Governance Committee recommended and approved the executive transition.
- Executive compensation totals corrected; no changes to voting matters or proposals.ALLO
Proxy filing21 May 2026 - Cema-cel shows strong MRD clearance and safety; cash runway extended to Q1 2029.ALLO
Q1 202620 May 2026 - Pivotal CAR T programs show strong efficacy, safety, and broad market potential.ALLO
Corporate presentation18 May 2026 - Pivotal trials advance, key data in 2026, cash runway into Q1 2028, net loss narrowed.ALLO
Q4 20253 May 2026 - Annual meeting to address director elections, executive pay, share increase, and auditor ratification.ALLO
Proxy filing1 May 2026 - Key votes include director elections, doubling authorized shares, and auditor ratification.ALLO
Proxy filing30 Apr 2026 - Key votes include director elections, executive pay, share increase, and auditor ratification.ALLO
Proxy filing20 Apr 2026 - Cema-cel achieved 58.3% MRD clearance and strong safety, supporting outpatient use in LBCL.ALLO
Study result20 Apr 2026 - Pivotal allogeneic CAR T programs target multi-billion dollar markets with key data in 2026.ALLO
Corporate presentation12 Mar 2026
Next Allogene Therapeutics earnings date
Next Allogene Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage